• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • WCW HOME
  • Submit a Wire!
  • Advertising
  • Media Partners
  • About
  • Contact Us

WorkCompWire

Your Trusted Source for Workers Compensation News

Enlyte
  • Workers Compensation News
    • Workers Compensation Industry News
    • Association, Rating & Research News
    • Claims, Legal, & Compliance News
    • Legislative & Regulatory News
    • Risk Management News
    • Work Force & Human Resource News
  • Featured Articles
  • Leaders Speak
  • Editor’s Forum
  • People On The Move

Cordant Health Solutions Discusses Importance of Continued Monitoring of Injured Workers

August 13, 2020 - WorkCompWire

Denver, CO – Cordant Health Solutions recently noted the importance of continued medication monitoring with injured workers during the pandemic.

With “stay-at-home” orders and concerns about exposing both injured workers and employees to COVID-19, in-person treatment, including the ability to monitor medication adherence through testing, has been limited.

In addition to dealing with their injuries, like many Americans, injured workers may also be living with newly developed mental health conditions brought on by the stress of the pandemic.

One poll conducted by Kaiser Family Foundation showed that 45% of all adult Americans say that the pandemic had a negative impact on their mental health, with 19% categorizing the impact as “major.”

Another report released by ExpressScripts shows a similar impact through the lens of prescription medications commonly used to treat mental health conditions. The report shows that prescriptions for anti-anxiety medications rose 34.1%, antidepressants 18.6% and anti-insomnia drugs 14.8% between Feb. 16 and March 15 this year.

“The combination of these types of drugs, which may be prescribed outside the workers’ compensation treatment plan, with opioids or other medications can lead to dangerous or even fatal reactions, including overdose,” said Cordant’s Chief Scientific and Technical Officer and Professor of Forensic and Clinical Toxicology at the City University of New York, Richard Stripp, Ph.D.

Cordant created a video-observed process using saliva for easy collection and observation over video. For the many clinicians switching to telemedicine, this process allows them to continue to test and monitor that the injured worker is adhering to their treatment program and not taking unknown medications or illicit drugs.

“Our clients expect us to engage clinicians and monitor adherence to treatment plans using drug testing,” said Tara Escobio, vice president of workers’ compensation for Cordant. “The remote option to observe the collection via video has been widely embraced by our clients and the clinicians treating the injured workers.”

Source: Cordant

Filed Under: Industry News, Top Stories, Workers' Compensation

Primary Sidebar

Get Our Free Newsletter:

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: WorkCompWire.com, PO Box 1114, Culver City, CA, 90232, http://www.workcompwire.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

myMatrixx

Paradigm

MSQ

Follow Us on Twitter

Tweets by WorkCompWire

Workers Compensation News Topics

  • Top Stories
  • Featured Articles
  • Leaders Speak
  • Editor’s Forum
  • The RxProfessor
  • Industry News
  • Association, Rating & Research News
  • People On The Move
  • Claims, Legal, & Compliance News
  • Legislative & Regulatory News
  • Risk Management News
  • Work Force & Human Resource News
  • Workers’ Compensation

Wire Archives

Copyright WorkCompWire © 2023